Taichung, Taiwan

Ming-You Shie


Average Co-Inventor Count = 7.5

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Ming-You Shie: Innovator in Cancer Treatment and Cell Therapy**

Introduction

Ming-You Shie, an inventor based in Taichung, Taiwan, has made significant contributions to the fields of cancer treatment and cellular research. With two patents to his name, his innovations focus on advancing therapeutic methods through groundbreaking scientific approaches.

Latest Patents

Ming-You Shie's latest patents include a fusion protein and nucleic acid encoding sequence, aimed at treating cancer and immunoregulation. The innovation demonstrates the ability to activate immune cells and has undergone various efficacy experiments to substantiate its therapeutic potential. His second patent relates to a tumor microenvironment on chip, a biochip designed for cell therapy. This invention utilizes microfluidic technology alongside cell culture to effectively detect and test the functions of cell therapies targeting cancer or tumors.

Career Highlights

Throughout his career, Ming-You Shie has collaborated with institutions such as China Medical University Hospital and China Medical University. His work in these prestigious organizations has contributed to his research and patent filings, positioning him as a notable figure in medical innovation.

Collaborations

In his professional journey, Ming-You Shie has worked alongside accomplished colleagues, including Yi-Wen Chen and Der-Yang Cho. These collaborations have enhanced his research and assisted in the development of his patents, fostering an environment of innovation and expertise.

Conclusion

Ming-You Shie's contributions to cancer treatment and cell therapy exemplify the power of innovation in medicine. With his two patents, he stands at the forefront of scientific advancement, paving the way for future research and breakthroughs in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…